VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN

被引：0
|
作者：
Ameri, A. [1 ]
Shahrad, B. [1 ]
Madani, H. [1 ]
Fazlalizadeh, A. [1 ]
Mousavizadeh, A. [1 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] Combination of trastuzumab, oxaliplatin, and docetaxel as first-line treatment in HER2-positive metastatic breast cancer patients: First-step results of a phase II trial (HOT trial)
    Amoroso, D.
    Donati, S.
    Valsuani, C.
    Puccetti, C.
    Rondini, M.
    Siclari, O.
    Tartarelli, G.
    Giannessi, P.
    Falcone, A.
    Camerini, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [23] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Drufakou, S
    Aperis, G
    Demiri, M
    Barbounis, V
    Missitzis, J
    Efremidis, AP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (02) : 179 - 183
  • [24] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    M. Vassilomanolakis
    G. Koumakis
    S. Drufakou
    G. Aperis
    M. Demiri
    V. Barbounis
    J. Missitzis
    A. Efremidis
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 179 - 183
  • [25] A Phase II trial of gemcitabine (G) and doxorubicin (D) combination as first line treatment of metastatic breast cancer: preliminary results
    Beldjillali, Y.
    Yamouni, M.
    Benhadji, K.
    Yekrou, D.
    Bahorah, Z.
    Djellali, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 130 - 130
  • [26] Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer
    Musolino, A.
    Bisagni, G.
    De Matteis, A.
    Nuzzo, F.
    Ardizzoni, A.
    Crino, L.
    Gamucci, T.
    Passalacqua, R.
    Gnoni, R.
    Boni, C.
    CANCER RESEARCH, 2010, 70
  • [27] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [29] Treatment of metastatic breast cancer with intensified combination of docetaxel and mitoxantrone: A multicenter phase II trial
    Alexopoulos, A
    Malamos, N
    Giannakakis, T
    Mauroudis, D
    Panagos, G
    Agelaki, S
    Kosmas, C
    Souglakos, J
    Vardakis, N
    Apostolaki, F
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1998, 9 : 27 - 27
  • [30] Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer
    Mlineritsch, Brigitte
    Schabel-Moser, Renate
    Andel, Johannes
    Fridrik, Michael
    Moik, Martin
    Mayer, Peter
    Russ, Gudrun
    Rass, Christof
    Greil, Richard
    ONKOLOGIE, 2009, 32 (1-2): : 18 - 24
12345